Mark Eisner - 04 Oct 2021 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Medical Officer
Signature
/s/ Dorothy Pacini, Attorney-in-fact
Issuer symbol
FGEN
Transactions as of
04 Oct 2021
Transactions value $
$0
Form type
4
Filing time
06 Oct 2021, 19:25:59 UTC
Next filing
03 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Award $0 +74.5K +212.91% $0.00 110K 04 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FGEN Stock Option (Right to Buy) Award $0 +44.5K $0.00 44.5K 04 Oct 2021 Common Stock 44.5K $9.93 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on each December 31, 2021, March 31, 2022, September 30, 2022 and March 31, 2023.
F2 Fifty percent of the shares subject to the option vests on each September 30, 2022 and March 31, 2023.